Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00275600
Other study ID # 1957-02
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received January 10, 2006
Last updated November 25, 2009
Start date January 2003
Est. completion date September 2007

Study information

Verified date November 2009
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study is being done to find out what effects Vitamin E or Evening Oil of Primrose has on cyclical breast pain.


Description:

Cyclical mastalgia is a common complaint of women presenting to their primary care physicians. Cyclical breast pain is defined as prementstrual breast discomfort associated with hormonal fluctuations during the menstrual cycle. A clinical breast examination and sometimes additional imaging, such as sonography or mammography, is required as part of the evaluation to exclude malignancy. For most women, the symptoms are effectively managed with reassurance and conservative treatment measures such as the use of a supportive bra or over the counter pain medication such as acetaminophen or anti-inflammatories. However, a small number of women will require additional drug treatment with danazol after failing to respond to conservative measures. Unfortunately, danazol is associated with significant side effects. In the Mayo Breast Clinic, women with cyclical breast pain are managed with Vitamin E and Evening oil of primrose (EOP) either as single agents or in combination. These over the counter supplements are readily available, acceptable due to minial side effects and appear to lead to significant reduction in breast pain. We propose a randomized placebo controlled trial to determine if any vitamin E or EOP or the combination of both are effective in managing cyclical breast pain.


Recruitment information / eligibility

Status Completed
Enrollment 82
Est. completion date September 2007
Est. primary completion date September 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 56 Years
Eligibility Inclusion Criteria:

- 18 years or older

- premenopausal

- cyclical breast pain

- breast pain survey indicating 3 or more on scale of 1-10

- if > 40 years of age, need normal mammogram and/or ultrasound if indicated and if not done within the last year

- if < 40 years of age, a directed ultrasound in the area of pain

- can be on oral contraceptives

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Vitamin E, Evening Oil of Primrose, and Placebo


Locations

Country Name City State
United States Mayo Clinic Rochester Minnesota

Sponsors (2)

Lead Sponsor Collaborator
Mayo Clinic New Health International

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Test if Vitamin E improves cyclical breast pain
Primary Test if Evening Oil of Primrose improves cyclical breast pain
Primary Test if combination of Evening Oil of Primrose and Vitamin E works synergistically for cyclial breast pain